Related Experiment Videos

Leukopenia due to penicillin and cephalosporin homologues

Insights

High doses of penicillin and cephalosporin antibiotics can cause leukopenia (low white blood cell count). Dosing should be weight-based, and blood counts monitored, especially after the first week of high-dose therapy.

Area of Science:

  • Pharmacology
  • Hematology
  • Infectious Diseases

Background:

  • Leukopenia is a rare complication associated with penicillin and cephalosporin antibiotics.
  • Clinical experience with this adverse effect is limited, necessitating further investigation.

Purpose of the Study:

  • To investigate the incidence and characteristics of leukopenia in patients receiving penicillin and cephalosporin antibiotics.
  • To evaluate the relationship between antibiotic dosage, duration, and the development of leukopenia.

Main Methods:

  • A review of nine patient cases experiencing leukopenia.
  • A literature review of 11 previously reported cases of antibiotic-induced leukopenia.
  • Analysis of dosage (mg/kg/day), duration of therapy, and timing of leukopenia onset.

Main Results:

  • Seventy-six percent of cases involved high doses (≥150 mg/kg/day) of penicillin or cephalosporins.
  • Sixty-seven percent of patients received high doses for ≥2 weeks before leukopenia onset.
  • Leukopenia typically occurred after the first week of antibiotic treatment.

Conclusions:

  • High-dose, prolonged therapy with penicillin and cephalosporins increases the risk of leukopenia.
  • Weight-based dosing (mg/kg/day) and monitoring blood cell counts are recommended, particularly after the first week of high-dose treatment.

Related Concept Videos